‘Acute Pain Therapeutics: Pipeline Assessment and Market Forecasts to 2017’ is now available at: www.pharmaceutical-market-research.com
The report is an essential source of information and analysis on the global acute pain market. It identifies the key trends shaping and driving the global acute pain market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report gives valuable insights on the pipeline products within the global acute pain sector.
The 73 page report estimates that the global acute pain therapeutics market was valued at $10.3 billion in 2010, and is forecast to grow at a CAGR of 4.7% over the next seven years, to reach $14.2 billion by 2017. This slow growth is primarily attributed to a low treatment seeking behaviour, disease awareness and usage of generic drugs. The current competitive landscape consists of branded, generic and off-label drugs.
